Success Metrics

Clinical Success Rate
78.3%

Based on 18 completed trials

Completion Rate
78%(18/23)
Active Trials
8(22%)
Results Posted
39%(7 trials)
Terminated
5(14%)

Phase Distribution

Ph phase_3
2
6%
Ph phase_2
4
11%
Ph early_phase_1
2
6%
Ph not_applicable
16
44%
Ph phase_4
3
8%

Phase Distribution

2

Early Stage

4

Mid Stage

5

Late Stage

Phase Distribution27 total trials
Early Phase 1First-in-human
2(7.4%)
Phase 2Efficacy & side effects
4(14.8%)
Phase 3Large-scale testing
2(7.4%)
Phase 4Post-market surveillance
3(11.1%)
N/ANon-phased studies
16(59.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.0%

18 of 25 finished

Non-Completion Rate

28.0%

7 ended early

Currently Active

8

trials recruiting

Total Trials

36

all time

Status Distribution
Active(9)
Completed(18)
Terminated(7)
Other(2)

Detailed Status

Completed18
Recruiting7
Terminated5
Withdrawn2
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
36
Active
8
Success Rate
78.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (7.4%)
Phase 24 (14.8%)
Phase 32 (7.4%)
Phase 43 (11.1%)
N/A16 (59.3%)

Trials by Status

terminated514%
withdrawn26%
completed1850%
active_not_recruiting13%
enrolling_by_invitation13%
recruiting719%
unknown26%

Recent Activity

Clinical Trials (36)

Showing 20 of 36 trialsScroll for more
NCT06254144

Neuroimaging Study for Decoding Emotional States and Identifying Neural Circuits to Disengage From Negative Thinking

Completed
NCT07540429Not Applicable

ADOLESCENTS IMAGING USING fMRI: Feasibility Study

Recruiting
NCT02966873Phase 2

Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)

Completed
NCT06314009

Beyond MARS: Magnetic Resonance Study: A Novel Assessment of Placental Perfusion During Pregnancy

Recruiting
NCT05795179Not Applicable

Stress & Self-Control Costs

Recruiting
NCT06724289Early Phase 1

Psilocybin for Prolonged Grief Disorder

Recruiting
NCT06503159Not Applicable

Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study

Terminated
NCT02810197Not Applicable

Resilience and Modification of Brain Control Network Following November 13

Completed
NCT06561165Not Applicable

Multifocal HD-tDCS and Motor Function

Recruiting
NCT04488757Not Applicable

Neurobiological Mechanisms of Stress in Youth With Chronic Widespread Pain

Active Not Recruiting
NCT06961864Not Applicable

Investigating Brain Function in People With and Without Visual Snow Syndrome Using Adaptation to Visual Stimuli

Recruiting
NCT06620042Phase 2

FMRI of Patients Receiving IV Ketamine for Treatment Resistant Bipolar Depression

Completed
NCT06688916

A Comprehensive Assessment of Altered Embodiment in Individuals With Spinal Cord Injury

Recruiting
NCT03117478Not Applicable

Brain and Mindfulness

Completed
NCT04402294Not Applicable

Individualized Closed Loop TMS for Working Memory Enhancement

Completed
NCT03638466Phase 2

Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD

Terminated
NCT02914951Not Applicable

Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability

Enrolling By Invitation
NCT02317783Phase 2

Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment

Terminated
NCT05934604Not Applicable

Targeting Large-scale Networks in Depression With Real-time fMRI (Functional Magnetic Resonance Imaging) Neurofeedback

Completed
NCT02798003

Food Reward in Cachexia Induced by Acute or Chronic Disease

Terminated

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
36